Similarly, there was a significant elevation in plasma creatinine concentration in the CIS-treated Gal-3 KO mice compared to Gal-3 KO control mice, also demonstrating statistical significance (p < 0.001) (Figure 1B). The gene discussed is LGALS3; the disease is in situ carcinoma.